ReviewAnnals of hematology2023

Superiority of polatuzumab vedotin over other novel agents in previously untreated ABC-type diffuse large B-cell lymphoma: a network meta-analysis of 20 RCTs.

Zhixin Sheng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.